general
Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
0% Left0% Center100% Right
Left (0)
No coverage found from this side yet.
Center (0)
No coverage found from this side yet.
Right (2)
New York PostRight
Trump’s FDA nominee could renew scrutiny to abortion drug risk: pro-life org CEO
"I think she's going to bring objectivity to the issue of mifepristone in a way that will expose this drug for the damage it causes women."
Aug 25, 2026
Fox NewsRight
Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Aug 25, 2026